Asia Pacific Pharmaceutical Drug Delivery Market Drivers and Forecasts by 2027
Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country
- Status : Published
- Report Code : TIPRE00011593
- Category : Life Sciences
- No. of Pages : 146
- Available Report Formats :
- Last update date : June 15, 2020
2019 Market Size
US$ 277,589.9 Mn
Base year value
2027 Forecast
US$ 473,700.1 Mn
Projected by 2027
CAGR 2020-2027
7.1 %
Growth rate
Addressable Market
US$ 3,061,233.35 Mn
(2020-2027)
The Asia Pacific pharmaceutical drug delivery market is anticipated to reach US$ 473,700.1 Mn by 2027 from US$ 277,589.9 Mn in 2019. The market is projected to grow at a CAGR of 7.1% from 2020 to 2027.
The pharmaceutical drug delivery market in this region is growing primarily due to the increasing shortage of medicines. However, the low availability of R&D funding by government in developing economies limits the growth of the market in Asia Pacific. On the other hand, growing emerging markets is expected to have a positive impact on the growth of the Asia Pacific pharmaceutical drug delivery market in the coming years.
Countries in Asia Pacific are emerging as attractive outsourcing locations for pharmaceutical industries. Low manufacturing and operating costs is the key factor that driving the growth of pharmaceutical industry in China and India, among others. Recent growth in the pharmaceuticals in both these countries indicate positive future outlook of the market players. Also, the growing domestic market and ongoing innovations in the drug delivery system are further opening new avenues for the pharmaceutical drug delivery players in APAC.
In 2019, China accounted for the largest share of the Asia Pacific pharmaceutical drug delivery market, and it is also expected to grow at a faster pace over the forecast period. The growing research activities in pharmaceutical drug delivery technologies and significant prevalence of disease are the key factors supporting the growth of the market in this country. Moreover, many markets players are focusing on geographic expansion in China.
China Pharmaceutical Drug Delivery Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Country
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- 3M
- Antares Pharma
- Bayer AG
- BD
- GlaxoSmithKline plc
Asia Pacific Pharmaceutical Drug Delivery Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 277,589.9 Million |
| Market Size by 2027 | US$ 473,700.1 Million |
| CAGR (2020 - 2027) | 7.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for